Biochemical, hematological and coagulation analyzes in patients with covid 19 disease

Session

Medicine and Nursing

Description

Introduction: Pathological analyzes of routine hematological, coagulation and biochemical tests enable the identification of patients with a poor prognosis and the early detection of complications of the COVID-19 disease. Analyzes must be interpreted in the context of the overall clinical picture of an individual patient, and monitoring changes at the level of individual parameters is also extremely important.

Materials and methods: A categorized and comprehensive literature search was conducted from 20 May 2021 to 25 July 2022 using international databases including PubMed, Embase, Web of Science, Scopus and the Cochrane Library in accordance with guideline recommendations to PRISMA. The PICO strategy was used to formulate the research question. The following terms were used: biochemical parameters in COVID-19, hematological parameters in COVID-19, blood coagulation parameters in COVID-19, indicators of inflammation, indicators of tissue damage in SARS-CoV-2.

Conclusion: Due to insufficient specificity, routine hematological, coagulation and biochemical tests are not used for the established diagnosis of the disease COVID-19, but are mainly used to assess the severity of the disease and to monitor the course of the disease and the effect of treatment.

Keywords:

COVID-19, SARS CoV2, Lymphopenia, Neutrophilia, CRP, D-dimer, Ferritin.

Proceedings Editor

Edmond Hajrizi

ISBN

978-9951-550-50-5

Location

UBT Kampus, Lipjan

Start Date

29-10-2022 12:00 AM

End Date

30-10-2022 12:00 AM

DOI

10.33107/ubt-ic.2022.163

This document is currently not available here.

Share

COinS
 
Oct 29th, 12:00 AM Oct 30th, 12:00 AM

Biochemical, hematological and coagulation analyzes in patients with covid 19 disease

UBT Kampus, Lipjan

Introduction: Pathological analyzes of routine hematological, coagulation and biochemical tests enable the identification of patients with a poor prognosis and the early detection of complications of the COVID-19 disease. Analyzes must be interpreted in the context of the overall clinical picture of an individual patient, and monitoring changes at the level of individual parameters is also extremely important.

Materials and methods: A categorized and comprehensive literature search was conducted from 20 May 2021 to 25 July 2022 using international databases including PubMed, Embase, Web of Science, Scopus and the Cochrane Library in accordance with guideline recommendations to PRISMA. The PICO strategy was used to formulate the research question. The following terms were used: biochemical parameters in COVID-19, hematological parameters in COVID-19, blood coagulation parameters in COVID-19, indicators of inflammation, indicators of tissue damage in SARS-CoV-2.

Conclusion: Due to insufficient specificity, routine hematological, coagulation and biochemical tests are not used for the established diagnosis of the disease COVID-19, but are mainly used to assess the severity of the disease and to monitor the course of the disease and the effect of treatment.